EA200000804A1 - Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина - Google Patents

Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина

Info

Publication number
EA200000804A1
EA200000804A1 EA200000804A EA200000804A EA200000804A1 EA 200000804 A1 EA200000804 A1 EA 200000804A1 EA 200000804 A EA200000804 A EA 200000804A EA 200000804 A EA200000804 A EA 200000804A EA 200000804 A1 EA200000804 A1 EA 200000804A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
azaclic
integrine
meta
inhibitors
Prior art date
Application number
EA200000804A
Other languages
English (en)
Inventor
Томас Э. Роджерз
Питер Г. Рамински
Original Assignee
Дж.Д.Сирл Энд Ко.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дж.Д.Сирл Энд Ко. filed Critical Дж.Д.Сирл Энд Ко.
Publication of EA200000804A1 publication Critical patent/EA200000804A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Abstract

Настоящее изобретение относится к соединениям формулы (I) и фармацевтически приемлемым солям и изомерам таких соединений, применимым в качестве антагонистов αβ-интегрина.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000804A 1998-03-04 1999-02-22 Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина EA200000804A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3427098A 1998-03-04 1998-03-04
PCT/US1999/003281 WO1999044994A1 (en) 1998-03-04 1999-02-22 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists

Publications (1)

Publication Number Publication Date
EA200000804A1 true EA200000804A1 (ru) 2001-04-23

Family

ID=21875345

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000804A EA200000804A1 (ru) 1998-03-04 1999-02-22 Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина

Country Status (29)

Country Link
EP (1) EP1060164A1 (ru)
JP (1) JP2002505323A (ru)
KR (1) KR20010041584A (ru)
CN (1) CN1214011C (ru)
AP (1) AP1244A (ru)
AR (1) AR018139A1 (ru)
AU (1) AU753230B2 (ru)
BG (1) BG104740A (ru)
BR (1) BR9908470A (ru)
CA (1) CA2322207A1 (ru)
EA (1) EA200000804A1 (ru)
EE (1) EE200000506A (ru)
GE (1) GEP20033118B (ru)
HR (1) HRP20000574A2 (ru)
HU (1) HUP0100865A3 (ru)
ID (1) ID25591A (ru)
IL (1) IL137653A0 (ru)
IS (1) IS5582A (ru)
MY (1) MY123908A (ru)
NO (1) NO315703B1 (ru)
NZ (1) NZ506598A (ru)
OA (1) OA11530A (ru)
PL (1) PL342726A1 (ru)
SK (1) SK13002000A3 (ru)
TR (1) TR200002542T2 (ru)
UA (1) UA71906C2 (ru)
WO (1) WO1999044994A1 (ru)
YU (1) YU52000A (ru)
ZA (1) ZA994406B (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
ES2295150T3 (es) 2000-04-17 2008-04-16 Ucb Pharma, S.A. Derivados de enamina como moleculas de adhesion celular.
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6921767B2 (en) * 2000-06-15 2005-07-26 Pharmacia Corporation Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
EP1305291A1 (en) 2000-08-02 2003-05-02 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
MXPA05006732A (es) * 2002-12-20 2005-09-08 Pharmacia Corp El isomero r de compuesto de beta-aminoacido como derivados de antagonistas de receptor de la integrina.
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
CA2612979A1 (en) * 2005-06-10 2006-12-21 Bipar Sciences, Inc. Parp modulators and treatment of cancer
EP2131861A2 (en) 2007-03-01 2009-12-16 Mallinckrodt Inc. Integrated photoactive small molecules and uses thereof
JP4792124B1 (ja) * 2010-11-15 2011-10-12 エフイートレード株式会社 車両用保護フィルムの型取り方法、及び、車両用保護フィルムの製造方法
WO2014015054A1 (en) 2012-07-18 2014-01-23 Saint Louis University Beta amino acid derivatives as integrin antagonists
US8716226B2 (en) 2012-07-18 2014-05-06 Saint Louis University 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
RU2016146826A (ru) 2014-05-30 2018-07-04 Пфайзер Инк. Производные карбонитрилов как селективные модуляторы андрогенового рецептора
BR112016028370B1 (pt) * 2014-06-04 2021-03-09 Monsanto Technology Llc processo para a preparação de compostos de ácido 3,6-diclorossalicílico
CN108779077A (zh) 2015-12-30 2018-11-09 圣路易斯大学 作为pan整合素拮抗剂的间位氮杂环氨基苯甲酸衍生物
CN115551846B (zh) 2020-05-14 2024-03-08 Ｕｂｅ株式会社 1,4,5,6-四氢嘧啶-2-胺衍生物
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE203234T1 (de) * 1995-08-30 2001-08-15 Searle & Co Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten

Also Published As

Publication number Publication date
PL342726A1 (en) 2001-07-02
CN1291978A (zh) 2001-04-18
EE200000506A (et) 2002-04-15
GEP20033118B (en) 2003-11-25
NZ506598A (en) 2003-07-25
AP2000001893A0 (en) 2000-09-30
YU52000A (sh) 2003-02-28
HUP0100865A3 (en) 2001-11-28
KR20010041584A (ko) 2001-05-25
EP1060164A1 (en) 2000-12-20
NO20004316L (no) 2000-11-06
NO20004316D0 (no) 2000-08-30
CA2322207A1 (en) 1999-09-10
JP2002505323A (ja) 2002-02-19
WO1999044994A1 (en) 1999-09-10
AR018139A1 (es) 2001-10-31
IL137653A0 (en) 2001-10-31
ZA994406B (en) 2000-02-11
OA11530A (en) 2004-05-17
HRP20000574A2 (en) 2001-08-31
BG104740A (en) 2001-02-28
NO315703B1 (no) 2003-10-13
AP1244A (en) 2004-02-04
AU3294799A (en) 1999-09-20
UA71906C2 (en) 2005-01-17
HUP0100865A2 (hu) 2001-08-28
TR200002542T2 (tr) 2001-05-21
BR9908470A (pt) 2000-12-05
AU753230B2 (en) 2002-10-10
MY123908A (en) 2006-06-30
CN1214011C (zh) 2005-08-10
SK13002000A3 (sk) 2001-07-10
ID25591A (id) 2000-10-19
IS5582A (is) 2000-08-04

Similar Documents

Publication Publication Date Title
EA200000804A1 (ru) Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина
EA199900591A1 (ru) АЗОТСОДЕРЖАЩИЕ ГЕТЕРОАРОМАТИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Ха
EA200300919A1 (ru) N-замещенные неарильные гетероциклические антагонисты nmda/nr2b
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
EA200200619A1 (ru) Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
DE69919397D1 (de) Thrombin-inhibitoren
EA200400361A1 (ru) Производные алкинарилнафтиридин-4(1h)-онов в качестве ингибитора фосфодиэстеразы типа iv
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
EA200401309A1 (ru) Тризамещённые гетероарилы и способы их получения и применения
EA200200938A1 (ru) Фармацевтические композиции, содержащие производные азетидина, новые производные азетидина и их получение
EA200200873A1 (ru) Новые пиперазиновые производные
EA200400981A1 (ru) Новые гетероциклические соединения, активные в качестве ингибиторов бета-лактамаз
EA200100203A1 (ru) Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов
ATE272633T1 (de) Aromatische amiden
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
EA200300674A1 (ru) Получение гетероциклических сульфонамидных ингибиторов бета-амилоида
EA199900166A1 (ru) Замещенные 6,6-гетеробициклические производные
EA200001122A1 (ru) Ингибиторы синтазы оксида азота
EA200400054A1 (ru) Замещенные нафтилиндольные производные в качестве ингибиторов ингибитора активатора плазминогена типа 1 (pai-1)
ATE374765T1 (de) Substituierte heterocyclische amide
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
PT1101755E (pt) Derivados do acido antranilico
EA200401301A1 (ru) Полициклические соединения как эффективные антагонисты альфа-2 адренорецептора